CGCABLE
834639
KLT
831689
DAYU BIOLOGICAL
871970
Fujian Superpipe
300198
WuHan Hvsen Biotechnology
300871
CN Stock MarketDetailed Quotes
605199 Hainan Huluwa Pharmaceutical Group
- 15.00
- +0.07+0.47%
Market Closed Mar 26 15:00 CST
6.00BMarket Cap53.19P/E (TTM)
15.05High14.67Low76.74KlotVolume14.68Open14.93Pre Close114.46MTurnover1.92%Turnover Ratio56.39P/E (Static)400.11MShares25.1652wk High5.20P/B6.00BFloat Cap9.0952wk Low16.42Limit Up400.11MShs Float49.61Historical High13.44Limit Down2.55%Amplitude5.96Historical Low0.13Dividend TTM14.92Avg Price37.67KlotAsk0.83%Div YieldTTM100Lot Size36.88KlotBid
Hainan Huluwa Pharmaceutical Group News
Huluwa: Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the resignation of the company\'s general manager and the appointment of the general manager
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the resignation of the company\'s general manager and the appointment of the general manager
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on Guangxi Weiwei Pharmaceutical Co., Ltd. providing a guarantee for its wholly-owned subsidiary
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on providing guarantees for wholly-owned subsidiaries
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the receipt of GMP compliance test results by its wholly-owned subsidiary
Huluwa: Announcement on Abnormal Stock Trading Fluctuations and Risk Alerts for Hainan Huluwa Pharmaceutical Group Co., Ltd.
Announcement on abnormal stock trading fluctuations and risk alerts of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Huluwa: Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock Trading Risk Warning Notice
Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock Trading Risk Warning Notice
Hainan Huluwa Pharmaceutical Group Co., Ltd. Stock Trading Risk Warning Notice
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Legal Opinion of Beijing Guofeng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the progress of capital increase for wholly-owned subsidiaries through debt-for-share swaps
Meeting materials of the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Huluwa Pharmaceutical Group Co., Ltd.
Notice of Hainan Huluwa Pharmaceutical Group Co., Ltd. on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on changing some fund-raising investment projects
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on by-election of independent directors
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the receipt of GMP compliance test results by its wholly-owned subsidiary
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on the resignation of an independent director at the end of their term of office
Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on increasing the capital of wholly-owned subsidiaries through debt-for-share swaps
